Hakim El Housni

1.4k total citations
31 papers, 711 citations indexed

About

Hakim El Housni is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Hakim El Housni has authored 31 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Genetics. Recurrent topics in Hakim El Housni's work include Cancer Genomics and Diagnostics (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Molecular Biology Techniques and Applications (4 papers). Hakim El Housni is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Molecular Biology Techniques and Applications (4 papers). Hakim El Housni collaborates with scholars based in Belgium, France and United Kingdom. Hakim El Housni's co-authors include Pierre Heimann, Barbara Dessars, Gilbert Vassart, Dominique Bron, Philippe Mineur, Stéphane Swillens, Basile Stamatopoulos, Nathalie Meuleman, Laurence Lagneaux and Marian A. J. Weterman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Hakim El Housni

31 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hakim El Housni Belgium	15	334	257	195	129	103	31	711
Masaya Taniwaki Japan	13	364 1.1×	294 1.1×	101 0.5×	210 1.6×	50 0.5×	49	761
Christopher Schroeder Germany	17	249 0.7×	308 1.2×	153 0.8×	162 1.3×	60 0.6×	53	740
Shelly Gunn United States	12	445 1.3×	298 1.2×	162 0.8×	91 0.7×	148 1.4×	28	814
Luca Ventura Italy	16	378 1.1×	239 0.9×	132 0.7×	142 1.1×	46 0.4×	59	735
Virginie Ory United States	12	401 1.2×	288 1.1×	128 0.7×	248 1.9×	73 0.7×	16	923
Margaret H. Veldman-Jones United Kingdom	8	358 1.1×	200 0.8×	146 0.7×	72 0.6×	51 0.5×	11	642
Barbara Hutter Germany	16	413 1.2×	160 0.6×	172 0.9×	116 0.9×	80 0.8×	33	751
Elisa Gruppioni Italy	15	274 0.8×	216 0.8×	136 0.7×	155 1.2×	73 0.7×	56	703
Yoo-Jin Kim Germany	18	326 1.0×	230 0.9×	168 0.9×	121 0.9×	80 0.8×	35	961
Chieki Wada Japan	17	331 1.0×	319 1.2×	208 1.1×	157 1.2×	71 0.7×	33	922

Countries citing papers authored by Hakim El Housni

Since Specialization

Citations

This map shows the geographic impact of Hakim El Housni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim El Housni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim El Housni more than expected).

Fields of papers citing papers by Hakim El Housni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakim El Housni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim El Housni. The network helps show where Hakim El Housni may publish in the future.

Co-authorship network of co-authors of Hakim El Housni

This figure shows the co-authorship network connecting the top 25 collaborators of Hakim El Housni. A scholar is included among the top collaborators of Hakim El Housni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakim El Housni. Hakim El Housni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seremet, Teofila, Yanina Jansen, H. Njimi, et al.. (2019). Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy. Journal of Translational Medicine. 17(1). 303–303. 96 indexed citations

Vandeputte, Caroline, Lieveke Ameye, Hakim El Housni, et al.. (2018). High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib.. Journal of Clinical Oncology. 36(15_suppl). 3532–3532. 2 indexed citations

D’Haene, Nicky, Marie Le Mercier, Nancy De Nève, et al.. (2015). Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers. PLoS ONE. 10(9). e0138245–e0138245. 67 indexed citations

Stamatopoulos, Basile, Michaël Van Damme, Emerence Crompot, et al.. (2015). Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia. Molecular Medicine. 21(1). 123–133. 55 indexed citations

Raymaekers, Marijke, Marleen Bâkkus, Elke Boone, et al.. (2011). Reflections and proposals to assure quality in molecular diagnostics.. PubMed. 66(1). 33–41. 7 indexed citations

Denys, Barbara, Hakim El Housni, Friedel Nollet, Bruno Verhasselt, & Jan Philippé. (2010). A Real-Time Polymerase Chain Reaction Assay for Rapid, Sensitive, and Specific Quantification of the JAK2V617F Mutation Using a Locked Nucleic Acid-Modified Oligonucleotide. Journal of Molecular Diagnostics. 12(4). 512–519. 23 indexed citations

Philippé, Jan, Friedel Nollet, Marleen Bâkkus, et al.. (2009). GUIDELINES FOR AN INTEGRATED DIAGNOSTIC APPROACH OF CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ROUTINE LABORATORY OF HAEMATOLOGY IN BELGIUM. Acta Clinica Belgica. 64(6). 494–504. 1 indexed citations

Ghisdal, Lidia, Christophe Baron, Yannick Le Meur, et al.. (2009). TCF7L2 Polymorphism Associates with New-Onset Diabetes after Transplantation. Journal of the American Society of Nephrology. 20(11). 2459–2467. 65 indexed citations

Meuleman, Nathalie, Basile Stamatopoulos, Marielle Dejeneffe, et al.. (2008). Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia. 22(10). 1882–1890. 21 indexed citations

10.

Dessars, Barbara, Renato Morandini, Anne Lefort, et al.. (2008). Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis. Journal of Investigative Dermatology. 129(1). 139–147. 43 indexed citations

11.

Horckmans, Michael, Anne Lefort, F. Libert, et al.. (2007). Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions. The Journal of Immunology. 179(6). 3550–3558. 16 indexed citations

12.

Heimann, Pierre, Hakim El Housni, Myriam Remmelink, et al.. (2007). Biclonal low grade B‐cell lymphoma confirmed by both flow cytometry and karyotypic analysis, in spite of a normal kappa/lambda Ig light chain ratio. American Journal of Hematology. 82(6). 473–480. 13 indexed citations

13.

Dessars, Barbara, Hakim El Housni, Renato Morandini, et al.. (2007). Chromosomal Translocations as a Mechanism of BRAF Activation in Two Cases of Large Congenital Melanocytic Nevi. Journal of Investigative Dermatology. 127(6). 1468–1470. 54 indexed citations

14.

Swillens, Stéphane, Barbara Dessars, & Hakim El Housni. (2007). Revisiting the sigmoidal curve fitting applied to quantitative real-time PCR data. Analytical Biochemistry. 373(2). 370–376. 30 indexed citations

15.

Dessars, Barbara, Pierre Heimann, Stéphane Swillens, & Hakim El Housni. (2006). Limitations and Practical Procedure in BclII-Ig Heavy Chain Gene Rearrangement Real-Time Quantitative Polymerase Chain Reaction. Journal of Molecular Diagnostics. 8(1). 133–136. 3 indexed citations

16.

Housni, Hakim El, Pierre Heimann, Jasmine Parma, & Gilbert Vassart. (2003). Single-Nucleotide Polymorphism Genotyping by Melting Analysis of Dual-Labeled Probes: Examples Using Factor V Leiden and Prothrombin 20210A Mutations. Clinical Chemistry. 49(10). 1669–1672. 27 indexed citations

17.

Ravoet, Christophe, Philippe Mineur, L Debusscher, et al.. (2002). Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML).. Blood. 100(11). 7 indexed citations

18.

Kentos, Alain, Christiane Knoop, Karl Martin Wissing, et al.. (2001). Anti-CD20 monoclonal antibody as first-line treatment of post-transplant B-lymphoproliferative disorders in solid organ transplant recipients. A report of 8 cases observed in a single center. Blood. 98. 4 indexed citations

19.

Pirson, Isabelle, et al.. (1999). Use of two-hybrid methodology for identifying proteins of interest in endocrinology. Molecular and Cellular Endocrinology. 151(1-2). 137–141. 2 indexed citations

20.

Housni, Hakim El, Raymond Lecocq, & Daniel Christophe. (1997). Production of dog calcyphosine in bacteria and lack of phosphorylation by the catalytic subunit of protein kinase A in vitro. Molecular and Cellular Endocrinology. 135(1). 93–97. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact